Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. (MLND) Stock Overview
Explore Millendo Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
11.1M
P/E Ratio
-0.04
EPS (TTM)
N/A
ROE
-0.78%
MLND Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Millendo Therapeutics, Inc. (MLND) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $2.14.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.04 and a market capitalization of 11.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.